Skip to main content

Recent Advances in Inducible Cyclooxygenase (COX-2) Inhibition

Buy Article:

$63.00 plus tax (Refund Policy)


Cyclooxygenase is the key enzyme in the biosynthesis of prostanoids, biologically active substances that are involved in several physio- logical processes but also in pathological conditions such as inflammation. Since ten years now, it is well known that this enzyme exists under two forms: a constitutive (COX-1) and an inducible form (COX-2). Both enzymes are sensitive to inhibition by conventional nonsteroidal anti-inflammatory drugs (NSAIDs). Observations that COX-1, involved in several homeostatic processes, played a housekeeping role while COX-2 expression was associated with inflammation and other pathologies such as cancer proliferation have led to the development of COX-2 selective inhibitors in order to reduce the classical side-effects, of which gastric irritation is the most common, associated with the use of conventional NSAIDs.

Keywords: COD-2; COX-1; COX-2 inhibitors; Cyclooxygenase (COX-2) Inhibition; Cyclooxygenase 1; Cyclooxygenase 2; Di-tert-butylphenols; Diaryl-substituted cycles; Furans; Inflammation; Methanesulfonanilide inhibitors; Nonsteroidal anti-inflammatory drugs (NSAIDs); Oxazoles and Isoxazoles; Prostanoids; Pyrazoles; Pyrroles; Thiophenes

Document Type: Review Article


Publication date: October 1, 2000

More about this publication?
  • Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Access Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more